Strides Pharma Science

Strides Pharma Science, an Indian pharmaceutical manufacturer, reported total carbon emissions of approximately 70,296,000 kg CO2e in 2025. This includes about 5,376,000 kg CO2e from Scope 1 emissions, 17,099,000 kg CO2e from Scope 2 emissions, and 47,827,000 kg CO2e from Scope 3 emissions. Key contributors to Scope 3 emissions include purchased goods and services (21,190,000 kg CO2e) and upstream transportation and distribution (11,051,000 kg CO2e).

In 2024, the company's Scope 1 emissions were approximately 5,331,800 kg CO2e and Scope 2 emissions were around 19,893,050 kg CO2e. In 2023, Scope 1 emissions were approximately 4,490,000 kg CO2e, and Scope 2 emissions were around 19,548,000 kg CO2e. Looking back to 2022, Scope 1 emissions were about 6,206,000 kg CO2e, and Scope 2 emissions were approximately 19,960,000 kg CO2e.

Strides Pharma Science has committed to a near-term target to reduce absolute total Scope 1 and Scope 2 emissions by 42% by FY2030, using FY2023 as the base year. The company is also in the process of formulating its long-term decarbonisation strategy and roadmap to contribute to the global Net Zero agenda for Scope 1 and Scope 2 emissions by 2050. Strides Pharma Science is a signatory to the Science Based Targets initiative (SBTi), having committed to Net Zero.